Treatment of platelet products with riboflavin and UV light: Effectiveness against high titer bacterial contamination

Journal of Visualized Experiments

Volumn 2015, Issue 102, 2015, Pages 1-7

  Keil, Shawn D ^a   Hovenga, Nick ^a   Gilmour, Denise ^a   Marschner, Susanne ^a   Goodrich, Raymond ^a  

^a Scientific Affairs   (Japan)

Author keywords

Bacteria; Immunology; Mirasol; Pathogen reduction technology; Platelet; Riboflavin; Ultra violet light

Indexed keywords

RIBOFLAVIN;

BACTERIAL COUNT; DRUG EFFECTS; HUMAN; MICROBIOLOGY; PROCEDURES; RADIATION RESPONSE; THROMBOCYTE; THROMBOCYTE TRANSFUSION; ULTRAVIOLET RADIATION;

BLOOD PLATELETS; COLONY COUNT, MICROBIAL; HUMANS; PLATELET TRANSFUSION; RIBOFLAVIN; ULTRAVIOLET RAYS;

EID: 84941215124     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/52820     Document Type: Article

References (22)

1. Brecher, M. E., Hay, S. N. Bacterial contamination of blood components. Clin. Microbiol. Rev. 18, (1), 195-204 (2005).
2. Brecher, M. E., Holland, P. V., Pineda, A. A., Tegtmeier, G. E., Yomtovian, R. Growth of bacteria in inoculated platelets: implications for bacteria detection and the extension of platelet storage. Transfusion. 40, (11), 1308-1312 (2000).
3. Cardo, L. J., et al. Pathogen inactivation of Leishmania donovani infantum in plasma and platelet concentrates using riboflavin and ultraviolet light. Vox Sang. 90, (2), 85-91 (2006).
4. Cardo, L. J., Salata, J., Mendez, J., Reddy, H., Goodrich, R. Pathogen inactivation of Trypanosoma cruzi in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfus. Apher. Sci. 37, (2), 131-137 (2007).
5. Dodd, R. Y. Current viral risks of blood and blood products. Ann. Med. 32, (7), 469-474 (2000).
6. Dodd, R. Y. Bacterial contamination and transfusion safety: experience in the United States. Transfus. Clin. Biol. 10, (1), 6-9 (2003).
7. Dumont, L. J., et al. Screening of single-donor apheresis platelets for bacterial contamination: the PASSPORT study results. Transfusion. 50, (3), 589-599 (2010).
8. Goodrich, R. P., Gilmour, D., Hovenga, N., Keil, S. D. A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns. Transfusion. 49, (6), 1205-1216 (2009).
9. Greco-Stewart, V. S., et al. Serratia marcescens strains implicated in adverse transfusion reactions form biofilms in platelet concentrates and demonstrate reduced detection by automated culture. Vox Sang. 102, (3), 212-220 (2012).
10. Keil, S. D., et al. Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light. Transfusion. 53, (10), 2278-2286 (2013).
11. Kleinman, S., Chan, P., Robillard, P. Risks associated with transfusion of cellular blood components in Canada. Transfus. Med Rev. 17, (2), 120-162 (2003).
12. Larsen, C. P., Ezligini, F., Hermansen, N. O., Kjeldsen-Kragh, J. Six years' experience of using the BacT/ALERT system to screen all platelet concentrates, and additional testing of outdated platelet concentrates to estimate the frequency of false-negative results. Vox Sang. 88, (2), 93-97 (2005).
13. Mundt, J. M., Rouse, L., Van den Bossche, J., Goodrich, R. P. Chemical and Biological Mechanisms of Pathogen Reduction Technologies. Photochem. Photobiol. (2014).
14. Murphy, W. G., et al. Screening platelet concentrates for bacterial contamination: low numbers of bacteria and slow growth in contaminated units mandate an alternative approach to product safety. Vox Sang. 95, (1), 13-19 (2008).
15. Brien, S. F., et al. Current incidence and residual risk of HIV, HBV and HCV at Canadian Blood Services. Vox Sang. 103, (1), 83-86 (2012).
16. Pearce, S., Rowe, G. P., Field, S. P. Screening of platelets for bacterial contamination at the Welsh Blood Service. Transfus. Med. 21, (1), 25-32 (2011).
17. Ramirez-Arcos, S., Kou, Y., Perkins, H. Evaluation of a universal point-of-issue assay for bacterial detection in buffy coat platelet components. Vox Sang. 107, (2), 192-195 (2014).
18. Reddy, H. L., et al. Toxicity testing of a novel riboflavin-based technology for pathogen reduction and white blood cell inactivation. Transfus. Med. Rev. 22, (2), 133-153 (2008).
19. Ruane, P. H., et al. Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light. Transfusion. 44, (6), 877-885 (2004).
20. Tonnetti, L., Proctor, M. C., Reddy, H. L., Goodrich, R. P., Leiby, D. A. Evaluation of the Mirasol pathogen reduction technology system against Babesia microti in apheresis platelets and plasma. Transfusion. 50, (5), 1019-1027 (2010).
21. Vanlandingham, D. L., et al. Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system. Transfusion. 53, (2), 284-290 (2013).
22. Walther-Wenke, G., et al. Monitoring bacterial contamination of blood components in Germany: effect of contamination reduction measures. Vox Sang. 100, (4), 359-366 (2011).